je.st
news
The Janssen-Achillion Deal Proves My Short Thesis
2015-05-26 00:13:52| Food - Topix.net
Janssen signed a deal with Achillion under which Janssen can use one or more of ACHN's Hepatitis C assets. ACHN's Hep C assets include an NS5A inhibitor ACH-3102, NS5B nuc ACH-3422, and Sovaprevir which is an NS3/4A Protease Inhibitor.
Tags: short
deal
thesis
proves
Category:Food and Related Products
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||